A61P 21 - Drugs for disorders of the muscular or neuromuscular system

Patents for A61P 21 - Drugs for disorders of the muscular or neuromuscular system (23,287)
11/2001
11/01/2001	CA2405565A1 Compounds for treating fibromyalgia and chronic fatigue syndrome
11/01/2001	CA2405170A1 Method of treatment using phenyl and biaryl derivatives as prostaglandin e inhibitors and compounds useful therefore
10/2001
10/31/2001	EP1149903A1 ADAMTS polypeptides, nucleic acids encoding them, and uses thereof
10/31/2001	EP1149072A1 Sulfonamide hydroxamates
10/31/2001	EP1148902A1 Method of enhancing needleless transdermal powdered drug delivery
10/31/2001	EP1148873A2 Highly purified ethyl epa and other epa derivatives for psychiatric and neurological disorders
10/31/2001	EP1148779A2 Expression of secreted human alpha-fetoprotein in transgenic animals
10/31/2001	CN1319425A Medical preparation for stasis-eliminating and soothing sinew
10/31/2001	CN1319408A Medicated liquor for treating traumatic injury
10/30/2001	US6310213 Good affitity to the nmda receptor and they are therefore useful in the treatment of neurodegenerative diseases
10/30/2001	US6310196 DNA construct for immunization or gene therapy
10/30/2001	US6309877 Polynucleotides encoding motoneuronotrophic factors
10/30/2001	US6309663 Triglyceride-free compositions and methods for enhanced absorption of hydrophilic therapeutic agents
10/30/2001	US6309645 A method of suppressing an immune response in a mammal.
10/26/2001	CA2319149A1 Medicament for treatment of duchenne muscular dystrophy
10/25/2001	WO2001083485A1 Imidazopyrimidine derivatives and triazolopyrimidine derivatives
10/25/2001	WO2001079480A1 Albumin fusion proteins
10/25/2001	WO2001079444A2 Albumin fusion proteins
10/25/2001	WO2001079443A2 Albumin fusion proteins
10/25/2001	WO2001079442A2 Albumin fusion proteins
10/25/2001	WO2001079282A2 Molecules associated with human reproduction
10/25/2001	WO2001079271A1 Albumin fusion proteins
10/25/2001	WO2001079258A1 Albumin fusion proteins
10/25/2001	WO2001079173A2 Enamine derivatives as cell adhesion molecules
10/25/2001	WO2001079170A2 Aminophenoxyacetamide derivatives and pharmaceutical composition containing thereof
10/25/2001	WO2001079153A1 Compounds, compositions and methods for preventing neurodegeneration in acute and chronic injuries in the central nervous system
10/25/2001	WO2001078754A2 Soft tissue and bone augmentation and bulking utilizing muscle-derived progenitor cells, compositions and treatments thereof
10/25/2001	WO2001078726A1 New uses of imidazolylmethyl-pyridines
10/25/2001	WO2001078722A1 Pharmaceutical compositions containing 5-hydroxyoxindole and use thereof
10/25/2001	WO2001078533A2 Nutritional modules
10/25/2001	WO2001049288A9 Novel compounds and compositions as protease inhibitors
10/25/2001	WO2001012790A3 Isomerase proteins
10/25/2001	US20010034347 A pyrido(1,2-a)pyrazine compound
10/25/2001	US20010034340 Hormone replacement therapy
10/25/2001	US20010034337 Antiproliferative agents
10/25/2001	DE10019062A1 Use of known and new 2-guanidino-4-aryl-quinazoline derivatives as NHE-3 inhibitors useful for the treatment of e.g. hypertension, thrombosis, cardiac ischemia, peripheral and CNS ischemia
10/25/2001	CA2747325A1 Albumin fusion proteins
10/25/2001	CA2407531A1 Imidazopyrimidine derivatives and triazolopyrimidine derivatives
10/25/2001	CA2405709A1 Albumin fusion proteins
10/25/2001	CA2405701A1 Albumin fusion proteins
10/25/2001	CA2405563A1 Albumin fusion proteins
10/25/2001	CA2405557A1 Albumin fusion proteins
10/25/2001	CA2405550A1 Albumin fusion proteins
10/25/2001	CA2405525A1 Albumin fusion proteins
10/25/2001	CA2405451A1 Molecules associated with human reproduction
10/25/2001	CA2405377A1 Nutritional modules
10/25/2001	CA2370487A1 Aminophenoxyacetamide derivatives and pharmaceutical composition containing thereof
10/24/2001	EP1147776A2 Use of botulinum toxin type B for the manufacture of a medicament for the treatment of muscle spasms
10/24/2001	EP1147775A2 Use of botulinum toxin type B for the manufacture of a medicament for reducing pain associated with a muscle disorder
10/24/2001	EP1147136A1 DNA ENCODING A MAMMALIAN RECEPTOR (fb41a) AND USES THEREOF
10/24/2001	EP1146893A1 Neurite derived growth factors for use in the treatment of muscular dystrophy
10/24/2001	EP1146883A1 Modulation of immune response by ribavirin
10/24/2001	EP1146790A1 Compounds and methods
10/24/2001	EP1035824A4 A process for the preparation of ring-opened epothilone intermediates which are useful for the preparation of epothilone analogs
10/24/2001	CN1319139A Polynucleotide constructs and uses thereof
10/24/2001	CN1319013A Pharmaceutical agents for treatment of parkinson's diseae, ADHD and microadenomas
10/24/2001	CN1319008A Hydroxamate-containing cysteine and serine protease inhibitors
10/24/2001	CN1318387A Wound-treating external-use medicine
10/23/2001	US6307089 Biphenyl butyric acids and their derivatives as inhibitors of matrix metalloproteinases
10/23/2001	US6307060 Antispasmodic agents
10/23/2001	US6307021 Polypeptide; for use in the treatment of defects associated with amplified or decreased apoptosis
10/23/2001	US6306912 Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases
10/23/2001	US6306878 Pharmaceutical compositions containing hydroximic acid derivatives
10/23/2001	US6306863 Pyrrolo[3,4-d]pyrimidinone derivatives and their use as medicaments
10/23/2001	US6306841 Treatment of female sexual dysfunction
10/23/2001	US6306423 Biocompatible implant for continuous in vivo release of a neurotoxin over a treatment period extending from one month to five years
10/18/2001	WO2001077174A2 Human transporters and ion channels
10/18/2001	WO2001077166A1 Novel physiologically active peptides and use thereof
10/18/2001	WO2001077137A1 Albumin fusion proteins
10/18/2001	WO2001077101A1 Chemical compounds
10/18/2001	WO2001077100A2 Benzoamide piperidine compounds as substance p antagonists
10/18/2001	WO2001077087A1 Novel compounds
10/18/2001	WO2001076530A2 Il-8 receptor antagonists
10/18/2001	WO2001038548A3 Vectors capable of immortalizing non-dividing cells and cells immortalized with said vectors
10/18/2001	WO2001038316A3 Sulfonyl oxazole amines and their use as 5-ht6 receptor ligands
10/18/2001	WO2000039283A9 Use of cd40 engagement to alter t cell receptor usage
10/18/2001	US20010031782 Use of gamma-tocopherol and its oxidative metabolite LLU-alpha in the treatment of disease
10/18/2001	US20010031777 Heterocyclic compounds and their therapeutic use
10/18/2001	US20010031757 Administering compounds such as 3-(2-phenylethylamino)-6-methyl-1-(2-amino-6-methyl-5-methylene -carboxamidomethylpyridi nyl)-2-pyrazinone, N'-((1-(Aminoiminomethyl)4-piperidinyl) methyl)-N-(3,3- diphenylpropionyl)-L-proline amide
10/18/2001	US20010031740 Mixture containing organic halide
10/18/2001	US20010031260 Administering tumor necrosis factor antagonist; rheumatic diseases, skin disorders
10/18/2001	CA2405912A1 Albumin fusion proteins
10/18/2001	CA2405089A1 Benzoamide piperidine containing compounds and related compounds
10/18/2001	CA2404229A1 Human transporters and ion channels
10/18/2001	CA2403012A1 Chemical compounds
10/17/2001	EP1144682A2 Nucleic acids containing single nucleotide polymorphisms and methods of use thereof
10/17/2001	EP1144673A1 Methods of screening protease inhibitors, of inducing mice susceptible to hiv protease inhibitor-induced dyslipidemia, and genes associated therewith
10/17/2001	EP1144671A2 Enriched central nervous system cell populations
10/17/2001	EP1144648A1 Cyclic nucleotide-associated proteins
10/17/2001	EP1144614A2 33 human secreted proteins
10/17/2001	EP1144605A2 Dimethylarginine dimethylaminohydrolases
10/17/2001	EP1144598A2 Human homologues of proteins regulated by circadian rhythms
10/17/2001	EP1144443A2 Human membrane transport proteins
10/17/2001	EP1144409A2 Phenyl urea and phenyl thiourea derivatives
10/17/2001	EP1144390A2 Kinase inhibitors
10/17/2001	EP1144387A1 New benzimidazolone-, benzoxazolone-, or benzothiazolone derivatives as ion channel modulating agents
10/17/2001	EP1144305A1 NOVEL sPLA 2 INHIBITORS
10/17/2001	EP1143984A1 Egg anti-inflammatory composition and method of treating and preventing inflammation
10/17/2001	EP1143965A1 Carbocyclic potassium channel inhibitors
10/17/2001	EP1143961A2 Regulators of the ptc or smoothened pathway, compositions and uses related thereto

1 ... 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 ... 233